Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world.
Di Cosimo S, La Rocca E, Ljevar S, De Santis MC, Bini M, Cappelletti V, Valenti M, Baili P, de Braud FG, Folli S, Scaperrotta G, Volpi C, Vingiani A, Vernieri C, Verderio P, Miceli R, Pruneri G.
Di Cosimo S, et al. Among authors: de santis mc, de braud fg.
Front Mol Biosci. 2022 Sep 26;9:996434. doi: 10.3389/fmolb.2022.996434. eCollection 2022.
Front Mol Biosci. 2022.
PMID: 36225259
Free PMC article.